Grazoprevir / Elbasvir (MK-5172/MK-8742)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Grazoprevir / Elbasvir (MK-5172/MK-8742), covering 2017-01-11 to 2017-01-11. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077) [Phase 3]